MedTrace Logo

Intervention for Postpartum Infections Following Caesarean Section

NCT01891006 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2016-10-18

No results posted yet for this study

Summary

The purpose of this study is to examine whether Negative Pressure Wound Therapy is an effective wound treatment compared to conventional wound treatment in the period of time from reoperation to re-suturing in women having surgical wound rupture after Caesarean Section.

Conditions

  • Surgical Wound Infection
  • Infection; Cesarean Section
  • Cesarean Section; Dehiscence
  • Complications; Cesarean Section
  • Complications; Cesarean Section, Wound, Dehiscence
  • Wound; Rupture, Surgery, Cesarean Section

Interventions

DEVICE

Negative Pressure Wound Therapy

The Negative Pressure Wound Therapy are changed on the 2. day and removed on the 4. day after the re-operation.

OTHER

Standard wound dressing

The standard wound dressing is a a hydrofiber or alginate dressing used for open wounds

Sponsors & Collaborators

  • Region of Southern Denmark

    collaborator OTHER

  • University of Southern Denmark

    collaborator OTHER

  • Hvidovre University Hospital

    collaborator OTHER

  • Smith & Nephew, Inc.

    collaborator INDUSTRY

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Nana Hyldig, PhD Student · Odense University Hospital, department of Plastic Surgery, University of Southern Denmark, Faculty of Health Sciences, institute of Clinical Research, research unit, department of Gynaecology and Obstetrics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2014-11-30
Completion
2015-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01891006 on ClinicalTrials.gov